Here’s what you need to know.
1. The U.S. Justice Department and other agencies have not confirmed the settlement.
2. Mylan said it is now in the final stage of closing its settlement.
3. The Justice Department is investing Mylan over its decision to raise the costs of its EpiPen. The EpiPen projects to account for 6 percent of Mylan’s total sales in 2017.
More articles on coding, billing and collections:
MACRA patient engagement cheat sheet No. 1 — Leveraging patient engagement for MACRA success: An overview
Colorado rejects single-payer healthcare system — 4 points
10 key steps to immediately improve ASC finances
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
